RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...
FDA approval for RAPIBLYK® (landiolol) for use in pediatric patients with SVT provides first therapeutic option for these ...
AOP Health US, LLC today announced that the U.S. Food and Drug Administration (FDA) has approved RAPIBLYK (landiolol) for use in pediatric patients (from birth to This press release features ...
Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.
In a remarkable clinical achievement, Kauvery Hospital, Alwarpet, successfully treated a 71-year-old man with multiple ...
NCBioImpact, a public/private partnership created to bring together key resources to produce world-class biopharma ...
MedPage Today on MSN
Xanax Recalled; Influencer's Livestream Overdose; Hospital Fire Forces Evacuation
Health news and commentary gathered by MedPage Today staff ...
Scientists have long been racking their brains to crack the mechanism behind Alzheimer’s disease progression. They may have finally found a crucial clue. A research team from Heidelberg University in ...
Complex's print magazine is back. Sign Up to get access to the latest drops, exclusive products and insider updates. “Extension Girl”: How Amoy Pitters Became The Hairstylist of Turn-of-the-Millennium ...
Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...
Background and objective Kidney transplant recipients (KTRs) face elevated cardiovascular risk, partly due to reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results